Cargando…
DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia
DNA damage and alterations in the DNA damage response (DDR) are critical sources of genetic instability that might be involved in BCR-ABL1 kinase-mediated blastic transformation of chronic myeloid leukemia (CML). Here, increased DNA damage is detected by γH2AX foci analysis in peripheral blood monon...
Autores principales: | Popp, Henning D., Kohl, Vanessa, Naumann, Nicole, Flach, Johanna, Brendel, Susanne, Kleiner, Helga, Weiss, Christel, Seifarth, Wolfgang, Saussele, Susanne, Hofmann, Wolf-Karsten, Fabarius, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072846/ https://www.ncbi.nlm.nih.gov/pubmed/32053969 http://dx.doi.org/10.3390/ijms21041177 |
Ejemplares similares
-
Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies
por: Kohl, Vanessa, et al.
Publicado: (2019) -
Separase activity distribution can be a marker of major molecular response and proliferation of CD34(+) cells in TKI-treated chronic myeloid leukemia patients
por: Spiess, Birgit, et al.
Publicado: (2020) -
Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10–100 kDa Fraction of Conditioned Medium
por: Kohl, Vanessa, et al.
Publicado: (2021) -
Leukocyte DNA damage after reduced and conventional absorbed radiation doses using 3rd generation dual-source CT technology
por: Popp, Henning D., et al.
Publicado: (2016) -
Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML
por: Christiani, Eva, et al.
Publicado: (2023)